 Lymphoproliferative Disorders
"Lymphoproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
| Descriptor ID |
D008232
|
| MeSH Number(s) |
C15.604.515 C20.683.515
|
| Concept/Terms |
Lymphoproliferative Disorders- Lymphoproliferative Disorders
- Disorder, Lymphoproliferative
- Disorders, Lymphoproliferative
- Lymphoproliferative Disorder
- Duncan's Syndrome
- Duncan Syndrome
- Duncans Syndrome
- Syndrome, Duncan's
X-Linked Lymphoproliferative Disorder- X-Linked Lymphoproliferative Disorder
- Disorder, X-Linked Lymphoproliferative
- Disorders, X-Linked Lymphoproliferative
- Lymphoproliferative Disorder, X-Linked
- Lymphoproliferative Disorders, X-Linked
- X Linked Lymphoproliferative Disorder
- X-Linked Lymphoproliferative Disorders
- X-Linked Lymphoproliferative Syndrome
- Lymphoproliferative Syndrome, X-Linked
- Lymphoproliferative Syndromes, X-Linked
- Syndrome, X-Linked Lymphoproliferative
- Syndromes, X-Linked Lymphoproliferative
- X Linked Lymphoproliferative Syndrome
- X-Linked Lymphoproliferative Syndromes
|
Below are MeSH descriptors whose meaning is more general than "Lymphoproliferative Disorders".
Below are MeSH descriptors whose meaning is more specific than "Lymphoproliferative Disorders".
This graph shows the total number of publications written about "Lymphoproliferative Disorders" by people in this website by year, and whether "Lymphoproliferative Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 0 | 1 | | 1981 | 1 | 0 | 1 | | 1982 | 0 | 1 | 1 | | 1988 | 1 | 1 | 2 | | 1989 | 1 | 0 | 1 | | 1991 | 2 | 0 | 2 | | 1992 | 2 | 0 | 2 | | 1993 | 2 | 4 | 6 | | 1994 | 1 | 0 | 1 | | 1995 | 1 | 1 | 2 | | 1996 | 2 | 2 | 4 | | 1997 | 5 | 1 | 6 | | 1998 | 3 | 0 | 3 | | 1999 | 7 | 2 | 9 | | 2000 | 2 | 3 | 5 | | 2001 | 3 | 2 | 5 | | 2002 | 2 | 2 | 4 | | 2003 | 1 | 1 | 2 | | 2005 | 4 | 1 | 5 | | 2006 | 2 | 1 | 3 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 1 | 2 | | 2009 | 2 | 2 | 4 | | 2010 | 3 | 1 | 4 | | 2011 | 3 | 2 | 5 | | 2014 | 2 | 0 | 2 | | 2015 | 2 | 0 | 2 | | 2016 | 1 | 0 | 1 | | 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.
-
Tian S, Westbrook LM, Xiao SY, Zhang Y, Huang Y, Wang HL. The Morphologic Features of Primary Epstein-Barr Virus Infection in the Gastrointestinal Tract: An Approach to Correct Diagnosis. Am J Surg Pathol. 2019 09; 43(9):1253-1263.
-
Van Besien K, Bachier-Rodriguez L, Satlin M, Brown MA, Gergis U, Guarneri D, Hsu J, Phillips AA, Mayer SA, Singh AD, Soave R, Rossi A, Small CB, Walsh TJ, Rennert H, Shore TB. Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leuk Lymphoma. 2019 07; 60(7):1693-1696.
-
Dierickx D, Sprangers B, Van Besien K. HLA: revisiting an old suspect in the complex pathogenesis of posttransplant lymphoproliferative disorders. Leuk Lymphoma. 2016 10; 57(10):2241-2.
-
Martires KJ, Ra S, Abdulla F, Cassarino DS. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders. Am J Dermatopathol. 2015 Nov; 37(11):822-33.
-
Ginat DT, Purakal A, Pytel P. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma. J Neurooncol. 2015 Nov; 125(2):297-305.
-
Lo R, Michalicek Z, Lazarus M. Mutlifocal osseous posttransplantation lymphoproliferative disorder: case report. Skeletal Radiol. 2015 Jul; 44(7):1021-6.
-
Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, Lyons JJ, Engelhardt KR, Zhang Y, Topcagic N, Roberson ED, Matthews H, Verbsky JW, Dasu T, Vargas-Hernandez A, Varghese N, McClain KL, Karam LB, Nahmod K, Makedonas G, Mace EM, Sorte HS, Perminow G, Rao VK, O'Connell MP, Price S, Su HC, Butrick M, McElwee J, Hughes JD, Willet J, Swan D, Xu Y, Santibanez-Koref M, Slowik V, Dinwiddie DL, Ciaccio CE, Saunders CJ, Septer S, Kingsmore SF, White AJ, Cant AJ, Hambleton S, Cooper MA. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015 Jan 22; 125(4):591-9.
-
Jericho H, Weinstein J, Melin-Aldana H, Leuer KC, Wyers M, Alonso EM, Ekong UD. Successful treatment with rituximab of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation. J Pediatr Gastroenterol Nutr. 2014 Jan; 58(1):e2-4.
-
Tran K, Hartman R, Tzu J, Meehan S, Sanders SE, Pomeranz MK, Sanchez M. Photolichenoid plaques with associated vitiliginous pigmentary changes. Dermatol Online J. 2011 Oct 15; 17(10):13.
-
Venkataraman G, Aguhar C, Kreitman RJ, Yuan CM, Stetler-Stevenson M. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders. Am J Clin Pathol. 2011 Oct; 136(4):625-30.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|